Contract W15QKN21C0012
Pfizer Inc · Department Of Defense · September 8, 2021
Pfizer Inc was awarded a federal contract by Department Of Defense (Department Of The Army) on September 8, 2021 for $861.13 million of work in biological product (except diagnostic) manufacturing. Performance is in New York, NY. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 24, 2021. If all options are exercised, the contract could reach $11.60 billion.
Contract details
- PIID
- W15QKN21C0012
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- New York, NY
- First action
- September 8, 2021
- Latest action
- September 24, 2021
Description
THE PURPOSE OF THIS ACTION IS TO SWAP FUNDING FOR 22.5M DOSES OF VACCINE AND REQUIRED DILUENT.
Modification timeline
-
September 24, 2021Mod P00016 · Funding Only Action$11.13B
-
September 20, 2021Mod P00015 · Supplemental Agreement For Work Within ScopeTHE PURPOSE OF THIS MODIFICATION IS TO ACCELERATE THE DELIVER SCHEDULE OF 22.5M DOSES OF ALREADY EXERCISED OPTIONS AND EXERCISE AN ADDITIONAL 50M DOSES WHILE CHANGING THE DELIVERED FORMULATION FROM RT…$11.13B
-
September 8, 2021Mod P00014 · Supplemental Agreement For Work Within ScopeTHE PURPOSE OF THIS MODIFICATION IS TO ACCELERATE THE DELIVER SCHEDULE OF 10M DOSES OF VACCINE.$11.13B
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Greer Laboratories, Inc. | Department Of Defense | December 19, 2025 | $470.4K |
| Greer Laboratories, Inc. | Department Of Defense | December 18, 2025 | $0 |
| Lifestream Blood Bank | Department Of Defense | December 18, 2025 | $29.7K |
| Kemp Proteins, Llc | Department Of Defense | December 18, 2025 | $40.0K |
| Applied Dna Sciences, Inc. | Department Of Defense | December 15, 2025 | $1 |
| Sanofi Vaccines Us Inc. | Department Of Defense | December 12, 2025 | $486.7K |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Advanced Technology International | 10 | $225.00M |
| 2 | Sanofi Vaccines Us Inc. | 5 | $27.10M |
| 3 | Meridian Medical Technologies, Llc | 2 | $16.41M |
| 4 | American National Red Cross, The | 12 | $5.59M |
| 5 | Boehringer Ingelheim Animal Health USA Inc | 3 | $3.53M |
| 6 | Versiti Blood Health, Inc. | 12 | $2.52M |
| 7 | American National Red Cross, The | 1 | $1.93M |
| 8 | Miltenyi Biotec, Inc. | 3 | $1.50M |
| 9 | Artemis Technologies Inc | 2 | $983.6K |
| 10 | Oklahoma Blood Institute | 3 | $885.0K |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W15QKN21C0012?
Contract W15QKN21C0012 is a federal contract awarded to Pfizer Inc by Department Of Defense on September 8, 2021 for $861.13 million of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 2 times since the base award.
Who won contract W15QKN21C0012?
Pfizer Inc won contract W15QKN21C0012 from Department Of Defense.
How much is contract W15QKN21C0012 worth?
Contract W15QKN21C0012 has obligated $861.13 million to date, with a total potential value of $11.60 billion if all options are exercised.